XML 49 R100.htm IDEA: XBRL DOCUMENT v2.4.0.8
Subsequent Events - Additional Information (Detail) (USD $)
12 Months Ended 0 Months Ended 0 Months Ended
Sep. 30, 2014
CareFusion Corporation [Member]
Oct. 03, 2014
Subsequent Event [Member]
Oct. 05, 2014
Subsequent Event [Member]
CareFusion Corporation [Member]
Oct. 05, 2014
Subsequent Event [Member]
CareFusion Corporation [Member]
Oct. 05, 2014
Subsequent Event [Member]
CareFusion Corporation [Member]
Interest Rate Swaps [Member]
Oct. 03, 2014
Subsequent Event [Member]
GenCell Biosystems [Member]
Business Acquisition [Line Items]            
Total consideration transferred per share of acquiree       $ 58    
Total consideration transferred     $ 12,200,000,000      
Acquisition agreement date Oct. 05, 2014   Oct. 05, 2014      
Percentage of outstanding shares acquired       100.00%    
Total cash consideration     10,100,000,000      
Currently secured financing     9,100,000,000      
Shares issuable to stockholders     2,100,000,000      
Cash consideration per share       $ 49.00    
Equity consideration per share       0.0777    
Share closing price   $ 115.84        
Description of Shares issuable to stockholders Under the terms of the transaction, CareFusion stockholders will receive $49.00 in cash, without interest, and 0.0777 of a share of BD for each share of CareFusion. Using BD’s closing price as of October 3, 2014 of $115.84 would result in a total cost of $58.00 per CareFusion share. The value of the consideration transferred for accounting purposes will ultimately be based on the closing share price of BD’s stock on the last trading day prior to the closing date of the transaction, and could materially change.          
Derivative, notional amount         $ 2,300,000,000  
Acquisition agreement date           Oct. 03, 2014